• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AFI
Click for more information
0.27% $7.47

AUSTRALIAN FOUNDATION INVESTMENT COMPANY LIMITED - Announcements

Market Cap $9.321B  ! watchlist Created with Sketch. Add to my watchlist

Australian Foundation Investment Company Limited is an investment company, which is... Australian Foundation Investment Company Limited is an investment company, which is focused on investing in Australian and New Zealand equities. Its investment objective is to provide shareholders with investment returns through access to a stream of franked dividends and growth of capital invested. It has two portfolios of securities: the investment portfolio and the trading portfolio. The investment portfolio holds securities which the Company intends to retain on a long-term basis and includes a small sub-component over which options may be written and an additional small sub-component of international (non-Australian/New Zealand listed stocks). The trading portfolio consist of securities that are held for short term trading only, including call option contracts written over securities that are held in the specific sub-component of the investment portfolio and on occasion put options and is relatively small in size. Its investment sectors include banks, healthcare, and materials.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
AFI Appendix 3B - Conversion of Convertible Notes31/08/15
AFI Appendix 3B - DRP and DSSP28/08/15
AFI Appendix 3Y - Change of Director's Interest Notice27/08/15
AFI Appendix 4G and Corporate Governance Statement27/08/15
AFI 2015 Annual Reports, Notice of AGM and Proxy Form27/08/15
AFI Retirement of Director - FD Ryan27/08/15
AFI Update - Dividend/Distribution - AFI14/08/15
AFI NTA & Top 25 Investments as at 31 July 201507/08/15
AFI Appendix 3Y - Change of Director's Interest Notice31/07/15
AFI NZSX Listing Rules Appendix 7 Form20/07/15
AFI Interest Payment - AFIG20/07/15
AFI Dividend/Distribution - AFI20/07/15
AFI Preliminary Final ReportPRICE SENSITIVE20/07/15
AFI NTA & Top 25 Investments as at 30 June 201502/07/15
AFI Key Dates24/06/15
AFI NTA & Top 25 Investments as at 31 May 201503/06/15
AFI Appendix 3Y - Change of Director's Interest Notice28/05/15
AFI Appendix 3Y - Change of Director's Interest Notice21/05/15
AFI NTA & Top 25 Investments as at 30 April 201504/05/15
AFI Appendix 3Y - Change of Director's Interest Notice24/04/15
AFI NTA & Top 25 Investments as at 31 March 201507/04/15
AFI Information Meetings - Presentation16/03/15
AFI NTA & Top 25 Investments as at 28 February 201505/03/15
AFI Appendix 3B - Conversion of Convertible Notes02/03/15
AFI Appendix 3Y - Change of Directors Interest Notices x 526/02/15
CWP +Ceasing to be a Substantial Holder from AFI20/02/15
AFI Appendix 3B - DRP and DSSP20/02/15
AFI Letter to Securityholders - Information Meetings19/02/15
AFI Half-Yearly Review to Shareholders19/02/15
AFI DRP and DSSP Price12/02/15
AFI NTA & Top 25 Investments as at 31 January 201503/02/15
AFI Appendix 3D - Renewal of on-market buy-back facilityPRICE SENSITIVE02/02/15
DUI +Replacement Change in Substantial Holding from AFI21/01/15
AFI NZSX Listing Rules Appendix 7 Form19/01/15
AFI Half Yearly Report and Accounts as at 31 December 2014PRICE SENSITIVE19/01/15
DUI +Change in Substantial Holding from AFI15/01/15
AFI AFI - NTA & Top 25 Investments as at 31 December 201407/01/15
AFI Key Dates17/12/14
AFI Appendix 3Y - Change of Directors Interest Notice12/12/14
AFI NTA & Top 25 Investments as at 30 November 201404/12/14
AFI NZ Information Meeting - PresentationPRICE SENSITIVE28/11/14
AFI NTA & Top 25 Investments as at 31 October 201406/11/14
AFI Appendix 3Y - Change of Director's Interest Notice23/10/14
AFI Appendix 3Y - Change of Directors Interest Notice16/10/14
AFI Appendix 3Y - Change of Directors Interest Notices x 710/10/14
AFI Results of 2014 AGM08/10/14
AFI 2014 AGM Presentation08/10/14
AFI Appendix 3B - Share Purchase Plan06/10/14
AFI AFI - NTA and Top 25 Investments as at 30 September 201403/10/14
AFI Appendix 3Y - Change of Directors Interest Notice02/10/14
AFI Share Purchase Plan PricePRICE SENSITIVE26/09/14
AFI Appendix 3Y - Change of Directors Interest Notice22/09/14
AFI NTA & Top 25 Investments as at 31 August 201404/09/14
AFI Appendix 3Y - Change of Directors Interest Notices x 404/09/14
AFI Appendix 3B - Conversion of Convertible Notes01/09/14
AFI Appendix 3B - DRP and DSSP29/08/14
AFI Letter to Shareholders - Share Purchase Plan28/08/14
AFI Cleansing Notice - Share Purchase Plan28/08/14
AFI 2014 Annual Reports, Notice of AGM and Proxy Form28/08/14
AFI DRP and DSSP Price15/08/14
AFI NTA & Top 25 Investments as at 31 July 201406/08/14
AFI Appendix 3Y - Change of Director's Interest Notice01/08/14
AFI NZSX Listing Rules Appendix 7 Form21/07/14
AFI Share Purchase PlanPRICE SENSITIVE21/07/14
AFI SPP - Cleansing Notice21/07/14
AFI Preliminary Final ReportPRICE SENSITIVE21/07/14
AFI AFI - NTA and Top 25 Investments as at 30 June 201403/07/14
AFI Amendments to DRP & DSSP Rules25/06/14
AFI 2014 Annual General Meeting25/06/14
AFI Key Dates25/06/14
AFI Appendix 3Y - Change of Director's Interest Notice16/06/14
AFI AFI - NTA & Top 25 Investments as at 31 May 201405/06/14
AFI +Change in substantial holding from AFI15/05/14
AFI AFI - NTA & Top 25 Investments as at 30 April 201406/05/14
AFI Tasmanian Information Meetings - Presentation05/05/14
AFI +Change in substantial holding from AFI30/04/14
AFI AFI - NTA & Top 25 Investments as at 31 March 201403/04/14
AFI Change of Director's Interest Notice27/03/14
AFI +Ceasing to be a substantial holder from AFI11/03/14
AFI Appendix 3B - Conversion of Convertible Notes11/03/14
AFI Information Meetings - Presentation11/03/14
AFI NTA & Top 25 Investments as at 28 February 201406/03/14
AFI Replacement Appendix 3B - Conversion of Convertible Notes03/03/14
AFI Appendix 3B - Conversion of Convertible Notes28/02/14
AFI Appendix 3Y - Change of Director's Interest Notices x 427/02/14
AFI Appendix 3B - DRP and DSSP21/02/14
AFI Letter to Securityholders - Information Meetings20/02/14
AFI Half-Yearly Review to Shareholders20/02/14
AFI Change of Director's Interest Notice13/02/14
AFI DRP and DSSP Price11/02/14
AFI AFI - NTA and Top 25 Investments as at 31 January 201405/02/14
AFI Appendix 3D - Renewal of on-market buy-back facilityPRICE SENSITIVE03/02/14
AFI NZSX Listing Rules Appendix 7 Form20/01/14
AFI Half Yearly Report and Accounts as at 31 December 2013PRICE SENSITIVE20/01/14
AFI AFI - NTA and Top 25 Investments as at 31 December 201307/01/14
AFI Change of Director's Interest Notice24/12/13
AFI Key Dates18/12/13
AFI Updated Securities Dealing Policy18/12/13
AFI Change of Director's Interest Notice16/12/13
AFI NTA & Top 25 Investments as at 30 November 201306/12/13
AFI Appendix 3B - Conversion of Convertible Notes
31/08/15
AFI Appendix 3B - DRP and DSSP
28/08/15
AFI Appendix 3Y - Change of Director's Interest Notice
27/08/15
AFI Appendix 4G and Corporate Governance Statement
27/08/15
AFI 2015 Annual Reports, Notice of AGM and Proxy Form
27/08/15
AFI Retirement of Director - FD Ryan
27/08/15
AFI Update - Dividend/Distribution - AFI
14/08/15
AFI NTA & Top 25 Investments as at 31 July 2015
07/08/15
AFI Appendix 3Y - Change of Director's Interest Notice
31/07/15
AFI NZSX Listing Rules Appendix 7 Form
20/07/15
AFI Interest Payment - AFIG
20/07/15
AFI Dividend/Distribution - AFI
20/07/15
AFI Preliminary Final Report
20/07/15PRICE SENSITIVE
AFI NTA & Top 25 Investments as at 30 June 2015
02/07/15
AFI Key Dates
24/06/15
AFI NTA & Top 25 Investments as at 31 May 2015
03/06/15
AFI Appendix 3Y - Change of Director's Interest Notice
28/05/15
AFI Appendix 3Y - Change of Director's Interest Notice
21/05/15
AFI NTA & Top 25 Investments as at 30 April 2015
04/05/15
AFI Appendix 3Y - Change of Director's Interest Notice
24/04/15
AFI NTA & Top 25 Investments as at 31 March 2015
07/04/15
AFI Information Meetings - Presentation
16/03/15
AFI NTA & Top 25 Investments as at 28 February 2015
05/03/15
AFI Appendix 3B - Conversion of Convertible Notes
02/03/15
AFI Appendix 3Y - Change of Directors Interest Notices x 5
26/02/15
CWP +Ceasing to be a Substantial Holder from AFI
20/02/15
AFI Appendix 3B - DRP and DSSP
20/02/15
AFI Letter to Securityholders - Information Meetings
19/02/15
AFI Half-Yearly Review to Shareholders
19/02/15
AFI DRP and DSSP Price
12/02/15
AFI NTA & Top 25 Investments as at 31 January 2015
03/02/15
AFI Appendix 3D - Renewal of on-market buy-back facility
02/02/15PRICE SENSITIVE
DUI +Replacement Change in Substantial Holding from AFI
21/01/15
AFI NZSX Listing Rules Appendix 7 Form
19/01/15
AFI Half Yearly Report and Accounts as at 31 December 2014
19/01/15PRICE SENSITIVE
DUI +Change in Substantial Holding from AFI
15/01/15
AFI AFI - NTA & Top 25 Investments as at 31 December 2014
07/01/15
AFI Key Dates
17/12/14
AFI Appendix 3Y - Change of Directors Interest Notice
12/12/14
AFI NTA & Top 25 Investments as at 30 November 2014
04/12/14
AFI NZ Information Meeting - Presentation
28/11/14PRICE SENSITIVE
AFI NTA & Top 25 Investments as at 31 October 2014
06/11/14
AFI Appendix 3Y - Change of Director's Interest Notice
23/10/14
AFI Appendix 3Y - Change of Directors Interest Notice
16/10/14
AFI Appendix 3Y - Change of Directors Interest Notices x 7
10/10/14
AFI Results of 2014 AGM
08/10/14
AFI 2014 AGM Presentation
08/10/14
AFI Appendix 3B - Share Purchase Plan
06/10/14
AFI AFI - NTA and Top 25 Investments as at 30 September 2014
03/10/14
AFI Appendix 3Y - Change of Directors Interest Notice
02/10/14
AFI Share Purchase Plan Price
26/09/14PRICE SENSITIVE
AFI Appendix 3Y - Change of Directors Interest Notice
22/09/14
AFI NTA & Top 25 Investments as at 31 August 2014
04/09/14
AFI Appendix 3Y - Change of Directors Interest Notices x 4
04/09/14
AFI Appendix 3B - Conversion of Convertible Notes
01/09/14
AFI Appendix 3B - DRP and DSSP
29/08/14
AFI Letter to Shareholders - Share Purchase Plan
28/08/14
AFI Cleansing Notice - Share Purchase Plan
28/08/14
AFI 2014 Annual Reports, Notice of AGM and Proxy Form
28/08/14
AFI DRP and DSSP Price
15/08/14
AFI NTA & Top 25 Investments as at 31 July 2014
06/08/14
AFI Appendix 3Y - Change of Director's Interest Notice
01/08/14
AFI NZSX Listing Rules Appendix 7 Form
21/07/14
AFI Share Purchase Plan
21/07/14PRICE SENSITIVE
AFI SPP - Cleansing Notice
21/07/14
AFI Preliminary Final Report
21/07/14PRICE SENSITIVE
AFI AFI - NTA and Top 25 Investments as at 30 June 2014
03/07/14
AFI Amendments to DRP & DSSP Rules
25/06/14
AFI 2014 Annual General Meeting
25/06/14
AFI Key Dates
25/06/14
AFI Appendix 3Y - Change of Director's Interest Notice
16/06/14
AFI AFI - NTA & Top 25 Investments as at 31 May 2014
05/06/14
AFI +Change in substantial holding from AFI
15/05/14
AFI AFI - NTA & Top 25 Investments as at 30 April 2014
06/05/14
AFI Tasmanian Information Meetings - Presentation
05/05/14
AFI +Change in substantial holding from AFI
30/04/14
AFI AFI - NTA & Top 25 Investments as at 31 March 2014
03/04/14
AFI Change of Director's Interest Notice
27/03/14
AFI +Ceasing to be a substantial holder from AFI
11/03/14
AFI Appendix 3B - Conversion of Convertible Notes
11/03/14
AFI Information Meetings - Presentation
11/03/14
AFI NTA & Top 25 Investments as at 28 February 2014
06/03/14
AFI Replacement Appendix 3B - Conversion of Convertible Notes
03/03/14
AFI Appendix 3B - Conversion of Convertible Notes
28/02/14
AFI Appendix 3Y - Change of Director's Interest Notices x 4
27/02/14
AFI Appendix 3B - DRP and DSSP
21/02/14
AFI Letter to Securityholders - Information Meetings
20/02/14
AFI Half-Yearly Review to Shareholders
20/02/14
AFI Change of Director's Interest Notice
13/02/14
AFI DRP and DSSP Price
11/02/14
AFI AFI - NTA and Top 25 Investments as at 31 January 2014
05/02/14
AFI Appendix 3D - Renewal of on-market buy-back facility
03/02/14PRICE SENSITIVE
AFI NZSX Listing Rules Appendix 7 Form
20/01/14
AFI Half Yearly Report and Accounts as at 31 December 2013
20/01/14PRICE SENSITIVE
AFI AFI - NTA and Top 25 Investments as at 31 December 2013
07/01/14
AFI Change of Director's Interest Notice
24/12/13
AFI Key Dates
18/12/13
AFI Updated Securities Dealing Policy
18/12/13
AFI Change of Director's Interest Notice
16/12/13
AFI NTA & Top 25 Investments as at 30 November 2013
06/12/13
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
$7.47 		Change
-0.020(0.27%) 		Mkt cap ! $9.321B
Open High Low Value Volume
$7.48 $7.49 $7.46 $2.501M 334.6K

Buyers (Bids)

No. Vol. Price($)
2 3952 $7.47
 

Sellers (Offers)

Price($) Vol. No.
$7.49 6108 2
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
Last
$7.47 		  Change
-0.020 ( 0.27 %)
Open High Low Volume
$7.49 $7.49 $7.46 115757
Last updated 15.59pm 15/11/2024 ?
AFI (ASX) Chart

Top Stories

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.